Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein. - Wikidata - awgldk - TriplyDB

Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein.

Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein.

http://www.wikidata.org/entity/Q33719533

about

The PI3K/AKT Pathway and Renal Cell Carcinoma VHL, the story of a tumour suppressor gene.New strategies in renal cell carcinoma: targeting the genetic and metabolic basis of disease.USP9X destabilizes pVHL and promotes cell proliferation.Targeting tumor suppressor genes for cancer therapy.Phosphorylation-dependent cleavage regulates von Hippel Lindau proteostasis and function.Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL.Bilateral Pheochromocytomas in a Patient with Y175C Von Hippel-Lindau Mutation

P2860

Q26800216-B029F55B-DA51-4EB1-8CE8-056348695880 Q34455226-62079EFC-B08C-420E-82A2-6B793CE6FE15 Q36696610-92343727-E99D-4C3A-9E4F-BB50206CDCFB Q37645058-418D9B32-475E-424B-B51B-7C225E7AA2F4 Q38601568-A932C766-96A5-4FDE-925A-6D6CA115FA85 Q38786652-8F230A9F-834C-4E9B-B36E-8E7B891C73C3 Q39004161-1132D35B-B951-4083-AB38-AFFA4F53593B Q57176537-7F31B661-FF58-44C6-BC96-91B36660A9E1

P2860

Genetic and pharmacological strategies to refunctionalize the von Hippel Lindau R167Q mutant protein.

http://www.wikidata.org/entity/Q33719533

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Genetic and pharmacological st ...... l Lindau R167Q mutant protein.

@ast

Genetic and pharmacological st ...... l Lindau R167Q mutant protein.

@en

type

label

Genetic and pharmacological st ...... l Lindau R167Q mutant protein.

@ast

Genetic and pharmacological st ...... l Lindau R167Q mutant protein.

@en

prefLabel

Genetic and pharmacological st ...... l Lindau R167Q mutant protein.

@ast

Genetic and pharmacological st ...... l Lindau R167Q mutant protein.

@en

P1433

Q33719533-02726938-B820-4985-840A-71F118B4DF4D

P1476

Q33719533-5B549E20-473C-4922-96BB-931978DE164F

P2093

Q33719533-03460EC9-45C0-4C46-A248-CC536932E72E

Q33719533-162C7739-8AAC-43EA-84C9-C3CA5586FA93

Q33719533-2B091907-0A4E-4812-B270-AE6226908336

Q33719533-3B27398B-647C-40B9-9160-732EE4384F30

Q33719533-56EE8F06-6031-4748-BA22-7F46C5328D61

Q33719533-5FDEF1B9-EF57-4D40-ACF9-4F1C758C778E

Q33719533-72800F26-0362-4EC5-BB3D-D7BBAABE3F48

Q33719533-87F31B0F-04C4-4EDC-AB1B-F3ECF5A4D6CC

Q33719533-C2D07924-CFEA-4FB1-8985-71411733669B

Q33719533-D3BDAD58-C4C9-41DE-9C6C-E3AC3EA2DC56

P2860

Q33719533-07AAB67C-D27B-4BEB-8FA8-734C238366C1

Q33719533-169AD2DC-C887-4D7F-B215-67AEFD923142

Q33719533-1A687819-8EAA-46D2-BE03-C23633EB92FD

Q33719533-234DD4E5-D237-4D5C-B726-BF5FCB371779

Q33719533-29B57662-BC07-4313-85EB-27E3B83EB6C8

Q33719533-29BFC18F-BCEA-474D-A289-EDDBFD789A7E

Q33719533-2CF68B64-1BD5-43B4-A962-6A754BB7885D

Q33719533-35859F41-6616-4157-9CF2-101D4DD215A0

Q33719533-40AE7639-7285-40B7-8AE4-A9BCDB783C1E

Q33719533-431FA604-AD93-48DE-9941-F84BE051A970

P304

Q33719533-47C9F591-1203-48DE-A6A7-A9D9724E02E8

P31

Q33719533-E0D07E51-4290-4F9D-8559-B3D21837A7F7

P356

Q33719533-262F375C-E5AC-4AE2-8198-94DCC48C218A

P407

Q33719533-D0161157-B1AA-4AF5-83AB-3A463E0CA089

P433

Q33719533-18317DF5-007E-49F1-8EAF-8AC45CD9BD73

P478

Q33719533-F5083861-CDA9-4CE8-A0BB-9B3F7F00F001

P577

Q33719533-251AF124-2384-449D-8547-E31DFD0CBB48

P5875

Q33719533-D8E944ED-E4C8-4E65-8630-073922807CC7

P698

Q33719533-4579920E-0F36-4CA6-B6F9-19940C611EC8

P932

Q33719533-42C13326-E229-47D0-A212-AC81566AC4BF

P356

0008-5472.CAN-13-3213

P1433

Cancer Research

P1476

Genetic and pharmacological st ...... l Lindau R167Q mutant protein.

@en

P2093

A Srinivas Reddy

http://www.w3.org/2001/XMLSchema#string

Chengbiao Wu

http://www.w3.org/2001/XMLSchema#string

Eric Jonasch

http://www.w3.org/2001/XMLSchema#string

Gordon B Mills

http://www.w3.org/2001/XMLSchema#string

Lijun Zhou

http://www.w3.org/2001/XMLSchema#string

Mianen Sun

http://www.w3.org/2001/XMLSchema#string

Peter German

http://www.w3.org/2001/XMLSchema#string

Shanshan Bai

http://www.w3.org/2001/XMLSchema#string

Shuxing Zhang

http://www.w3.org/2001/XMLSchema#string

Xian-De Liu

http://www.w3.org/2001/XMLSchema#string

P2860

VHL type 2B mutations retain VBC complex form and function

CITED2 mediates the paradoxical responses of HIF-1alpha to proteasome inhibition

Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C

The Protein Data Bank

Identification of the von Hippel-lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex

Dissecting Fragment-Based Lead Discovery at the von Hippel-Lindau Protein:Hypoxia Inducible Factor 1α Protein-Protein Interface

Comprehensive molecular characterization of clear cell renal cell carcinoma.

von Hippel-Lindau disease

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

P304

3127-3136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-13-3213

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261800834

http://www.w3.org/2001/XMLSchema#string

P698

24755468

http://www.w3.org/2001/XMLSchema#string

P932

4047720

http://www.w3.org/2001/XMLSchema#string